Volume 90 Issue 47 | p. 19 | Concentrates
Issue Date: November 19, 2012

GSK And Aptuit Extend Partnership

Department: Business
Keywords: contract research, Italy, pharmaceuticals
[+]Enlarge
A statue in the lobby of Aptuit’s Verona facility.
Credit: Aptuit
A statue in the lobby of Aptuit’s Verona, Italy, contract drug research and development facility.
 
A statue in the lobby of Aptuit’s Verona facility.
Credit: Aptuit

GlaxoSmithKline and the contract research firm Aptuit have agreed to a multiyear extension of a drug development partnership at Aptuit’s facility in Verona, Italy. Aptuit acquired the facility from GSK in 2010 as the drug company was shrinking its R&D footprint. Aptuit Chairman Timothy C. Tyson says the extension reaffirms the Verona site’s ability to deliver scientific excellence. The site has developed more than 90 other clients, he adds.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment